STAGE IVA HEPATOCELLULAR CARCINOMA AJCC V8
Clinical trials for STAGE IVA HEPATOCELLULAR CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVA HEPATOCELLULAR CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVA HEPATOCELLULAR CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for inoperable liver cancer
Disease control OngoingThis early-phase trial studies the safety and effectiveness of two immunotherapy drugs (durvalumab and tremelimumab) given after a targeted radiation procedure for patients with advanced liver cancer that cannot be removed by surgery. The treatment aims to help the immune system …
Matched conditions: STAGE IVA HEPATOCELLULAR CARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 04:27 UTC
-
New combo shows promise against tough liver cancer
Disease control OngoingThis study tests a new drug called pevonedistat, given alone or with standard chemotherapy, in 40 adults with advanced bile duct cancer that has spread or cannot be removed. The goal is to see if the combination can shrink tumors or stop them from growing. Participants must have …
Matched conditions: STAGE IVA HEPATOCELLULAR CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
Tailored radiation doses aim to shrink liver tumors
Disease control OngoingThis study tests whether giving a personalized dose of radiation directly to liver tumors can improve treatment results for people with advanced liver cancer that cannot be removed by surgery. About 42 participants will receive a customized radiation plan based on their individua…
Matched conditions: STAGE IVA HEPATOCELLULAR CARCINOMA AJCC V8
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:48 UTC